Rare Orbital Involvement Originating from Extranodal Marginal Zone Lymphoma

被引:0
|
作者
Wen, Yao-Chang [1 ]
Huang, Tzu-Chuan [2 ]
Tsai, Wen-Chiuan [3 ]
Lai, Shiue-Wei [2 ]
机构
[1] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Taipei 114202, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Hematol & Oncol, Taipei 114202, Taiwan
[3] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei 114202, Taiwan
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 05期
关键词
orbital tumor; orbital lymphoma; extranodal marginal zone lymphoma; B-CELL LYMPHOMA; OCULAR ADNEXAL LYMPHOMA; 1ST-LINE TREATMENT; RADIATION-THERAPY; RITUXIMAB; TISSUE; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; VINCRISTINE; DIAGNOSIS;
D O I
10.3390/medicina60050706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ocular adnexa region (OAR) primary lymphomas are uncommon, accounting for 1-2% of non-Hodgkin lymphomas and 8% of extranodal lymphomas. Extranodal marginal zone lymphoma (EMZL) originates from several epithelial tissues, including the stomach, salivary gland, lung, small intestine, thyroid gland, and ocular adnexa region. Here, we report a 66-year-old female patient who was diagnosed with EMZL of OAR. In consideration of the possible side effect of radiotherapy, such as conjunctivitis, visual acuity impairment, and even retinal complications, she received six cycles of triweekly targeted chemotherapy with rituximab, cyclophosphamide, vincristine, and prednisone (R-CVP) without radiotherapy. Then, she remained in complete remission up to the present day.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma
    Schreuder, Max I.
    van den Brand, Michiel
    Hebeda, Konnie M.
    Groenen, Patricia J. T. A.
    van Krieken, J. Han
    Scheijen, Blanca
    JOURNAL OF HEMATOPATHOLOGY, 2017, 10 (3-4) : 91 - 107
  • [42] A case of extranodal marginal zone lymphoma with extensive plasmacytic differentiation
    Lee, Jungsoo
    Noh, Seongmin
    Oh, Sang Ho
    Lee, Kwang Hoon
    JOURNAL OF DERMATOLOGY, 2012, 39 : 111 - 111
  • [43] Extranodal Marginal Zone Endobronchial Lymphoma Associated With Hepatitis C
    Bhatt, Nimish
    Sloan, Mark
    O'Hara, Carl J.
    Oommen, Roy
    Steiling, Katrina
    Litle, Virginia R.
    ANNALS OF THORACIC SURGERY, 2016, 102 (05): : E407 - E408
  • [44] Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency
    Desar, I. M. E.
    Keuter, M.
    Raemaekers, J. M. M.
    Jansen, J. B. M. J.
    van Krieken, J. H. J.
    van der Meer, J. W. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2006, 64 (05): : 136 - 140
  • [45] Low-grade dural extranodal marginal zone lymphoma
    Marguet, Florent
    Fontanilles, Maxime
    Bohers, Elodie
    Derrey, Stephane
    Langlois, Olivier
    Veresezan, Liana
    Lepretre, Stephane
    Sabourin, Jean-Christophe
    Jardin, Fabrice
    Laquerriere, Annie
    ANNALES DE PATHOLOGIE, 2020, 40 (03) : 243 - 247
  • [46] Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma
    Alderuccio, Juan Pablo
    Lossos, Izidore S.
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (05) : 333 - 348
  • [47] Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma
    Max I. Schreuder
    Michiel van den Brand
    Konnie M. Hebeda
    Patricia J. T. A. Groenen
    J. Han van Krieken
    Blanca Scheijen
    Journal of Hematopathology, 2017, 10 : 91 - 107
  • [48] Monoclonal gammmopathy (MG) in extranodal marginal zone lymphoma (ENMZL)
    Wohrer, S
    Raderer, M
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (04) : 312 - 312
  • [49] Genetic Landscape of Ocular Adnexa Extranodal Marginal Zone Lymphoma
    Magistri, Marco
    Happ, Lanie
    Ramdial, Jeremy
    Kunkalla, Kranthi
    Dubovy, Sander R.
    Chapman, Jennifer R.
    Vega, Francisco
    Dave, Sandeep
    Lossos, Izidore S.
    BLOOD, 2018, 132
  • [50] Extranodal Marginal Zone B Cell (MALT) Lymphoma of the Esophagus
    Tabibian, James H.
    Kalani, Amir
    Moran, Anna M.
    Panganamamula, Kashyap
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 1034 - 1036